Catalyst Wire Dossier Catalyst Wire Dossier

CLONICEL

clonidine sustained-release · Addrenex Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CLONICEL, covering 2010-03-24 to 2012-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]

See pricing